eli lilly cease and desist letter tirzepatide The FDA says it's standing by its earlier decision that the shortage of — the active ingredient in Lilly's diabetes weight loss drugs Mounjaro and Zepbound — is over Compounded versions of tirzepatide (Mounjaro,

(And Who Doesnt) Tirzepatide may be especially helpful for men who: have obesity or excess visceral fat show signs of insulin resistance or metabolic syndrome have borderline or mildly low testosterone experience fatigue, low libido, or reduced energy tied to metabolic health It may be less effective for men with: primary hypogonadism genetic or structural hormone disorders very low baseline testosterone unrelated to metabolic health Limitations and Realistic Expectations While tirzepatide shows promise, it is not a guaranteed solution for low testosterone

This pharmacokinetic design is why weeklynot every-5-daydosing is the gold standard

ACKNOWLEDGMENTS The authors thank Alison Sherwin, PhD, from Edanz ( for editing a draft of the manuscript

Personalized Treatment Plan : We understand that each persons journey is unique

Continuous treatment indicates long-term success in weight loss and supports helpful lifestyle changes

These foundational elements are essential for achieving sustainable weight reduction and overall health improvement